MEA HBOT Devices Market

MEA HBOT Devices Market Size (2023 to 2028)

The size of the Hyperbaric Oxygen (HBO) Therapy Devices Market in the Middle East and Africa is estimated to grow USD 21.33 million by 2028 from USD 15.72 million in 2023. It is expected to grow at a CAGR of 6.3% from 2023 to 2028. It captures 8% of the global market.

Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.

Development of the global hyperbaric oxygen therapy devices market is primarily driven by increasing prevalence of acute and chronic wounds and rising incidence of wound site infections. Moreover, raise in the demand for leisure adventure activities is anticipated to drive growth of the global hyperbaric oxygen therapy devices market over the aforementioned forecast period.

However, high cost of hyperbaric oxygen therapy devices and reimbursement coverage are factors restraining market growth; these could also obstruct further product development and overall demand for hyperbaric oxygen therapy devices.

The market is segmented by product and application. By product the market is segmented into Monoplace HBOT Devices, Multiplace HBOT Devices, and Topical HBOT Devices. Monoplace HBOT devices is the market leader capturing over 76% of the total revenue in 2018. The commercial availability of Monoplace systems and increased adoption of such devices, owing to ease of handling and less requirement of hospital gas supply are few factors that are responsible for its revenue share in 2018. Furthermore, the Monoplace HBOT devices category is likely to witness the highest CAGR. The steadily rising demand for Monoplace systems in hospitals & clinics owing to its higher availability in the market is the key factor, which is likely to boost market growth. Multiplace hyperbaric chamber is growing with the highest CAGR. But still, the rising requirement of treating growing number of patients in one cycle has resulted in raised demand for such systems in large-scale hospitals, which is expected to drive the market over the aforementioned forecast period.

Companies have a presence in the MEA HBOT devices market include Gulf Coast Hyperbarics, Inc.; Fink Engineering; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); HAUX-LIFE-SUPPORT; HEARMEC; IHC Hytech B.V. (Royal IHC); Hyperbaric SAC; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Middle East and Africa Ltd.